Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease

Blood (2021) 137 (7): 896–907.

https://doi.org/10.1182/blood.2020006892

Published: 2021

Includes: Supplemental data

Journal Articles

Clinical Characterization and Cytokine Profile of Fatigue in Patients with Chronic Gvhd

Sencer Goklemez, MD, Saligan Leorey, PhD, Filip Pirsl, Seth M. Steinberg, PhD, Sandra A Mitchell, PhD, Frances T. Hakim, PhD, Jeremy J. Rose, MS, Zhigang Kang, MD, Yunkai Yu, Liang Cao, Annie Im, MD, Steven Z. Pavletic, MD MS

Blood (2019) 134 (Supplement_1): 3282.

https://doi.org/10.1182/blood-2019-124055

Published: 2019

Journal Articles

A Large Cohort Comparison of 2005 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria to 2014 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria

Blood (2017) 130 (Supplement 1): 4720.

https://doi.org/10.1182/blood.V130.Suppl_1.4720.4720

Published: 2017

Journal Articles

Final Results of a Randomized Phase 2 Trial Evaluating Lower-Dose Versus Higher-Dose Pomalidomide as Therapy for Corticosteroid-Refractory Chronic Gvhd

Lauren M. Curtis, MD, David Venzon, PhD, Fran T. Hakim, PhD, Edward W. Cowen, MD MHSc, Jennifer Hsu, RN, Licia Masuch, Jacqueline W. Mays, DDS, MHSc, PhD, Sandra A. Mitchell, CRNP, PhD AOCN, Filip Pirsl, Iskra Pusic, MD, Jeremy J. Rose, MS, Zoya J. Kuzmina, MD PhD, Kristin Baird, MD, Robert Peter Gale, Daniel H. Fowler, MD, Ronald E. Gress, MD, Steven Z. Pavletic, MD

Blood (2016) 128 (22): 507.

https://doi.org/10.1182/blood.V128.22.507.507

Published: 2016

Journal Articles

Clinical and Immunologic Characteristics of Patients with Chronic Graft-Versus-Host Disease Persisting Seven or More Years after Diagnosis

Annie Im, MD, Frances T. Hakim, PhD, Filip Pirsl, Seth M. Steinberg, PhD, Lauren M. Curtis, MD, Sandra A. Mitchell, CRNP, PhD AOCN, Edward W. Cowen, MD MHSc, Jennifer Hsu, RN, Judy Baruffaldi, Licia Masuch, Juan C. Gea-Banacloche, MD, David C. Halverson, MD, Daniel H. Fowler, MD, Ronald E. Gress, MD, Steven Z. Pavletic, MD

Blood (2015) 126 (23): 1937.

https://doi.org/10.1182/blood.V126.23.1937.1937

Published: 2015

Journal Articles

Comorbidity Significantly Impairs Quality Of Life In Patients After Allogeneic Hematopoietic Stem Cell Transplantation – Results From The Prospective German Multicenter Validation Trial

Daniel Wolff, MD, Philipp Y. Herzberg, PhD, Steven Z. Pavletic, MD, Pia Heussner, MD, Friederike Mumm, MD, Christina Balsiger, MD, Inken Hilgendorf, MD, Philipp Hemmati, MD, Ernst Holler, MD, PhD, Hildegard T Greinix, MD, Sandra A. Mitchell, PhD

Blood (2013) 122 (21): 2073.

https://doi.org/10.1182/blood.V122.21.2073.2073

Published: 2013

Journal Articles

Development and Preliminary Testing Of The Post-Transplant Multimorbidity Index (PTMI)

Sandra A. Mitchell, PhD, CRNP, Steven Z. Pavletic, MD, Ernst Holler, MD, PhD, Philipp Y. Herzberg, PhD, Pia Heussner, MD, Hildegard T Greinix, Bernhard Banas, MD, Daniel Wolff, MD, PhD

Blood (2013) 122 (21): 2076.

https://doi.org/10.1182/blood.V122.21.2076.2076

Published: 2013

Journal Articles

Chronic Graft-Versus-Host Disease (cGVHD) Patients with Bronchiolitis Obliterans Syndrome (BOS) Have Worse Clinical Manifestations and Severity of cGVHD with More Impairment in Self-Assessed Physical and Mental Health than cGVHD Patients without BOS

Lana Grkovic, MD, Drazen Pulanic, MD, PhD, Seth M. Steinberg, PhD, Kirsten M. Williams, MD, Kristin Baird, MD, Sandra A. Mitchell, PhD, Edward W. Cowen, MD, Manuel B. Datiles, III, MD, Carol W. Bassim, DMD, Joe Galen, MD, Leora Comis, Daniele N. Avila, CRNP, Tiffani N. Taylor, PA, Dan Zhang, Mrs., Kristen Cole, RN, Dan H. Fowler, MD, Frances T. Hakim, PhD, Ronald E. Gress, MD, Steven Z. Pavletic, MD

Blood (2012) 120 (21): 1939.

https://doi.org/10.1182/blood.V120.21.1939.1939

Published: 2012

Journal Articles

Assessing the Validity of the NIH Response Criteria for Chronic Graft-Versus-Host Disease (cGVHD): Consensus Measures Correlate with Clinical Outcomes,

Blood (2011) 118 (21): 4074.

https://doi.org/10.1182/blood.V118.21.4074.4074

Published: 2011

Journal Articles

Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease

Kathryn J. Martires, Kristin Baird, Seth M. Steinberg, Lana Grkovic, Galen O. Joe, Kirsten M. Williams, Sandra A. Mitchell, Manuel Datiles, Fran T. Hakim, Steven Z. Pavletic, Edward W. Cowen

Blood (2011) 118 (15): 4250–4257.

https://doi.org/10.1182/blood-2011-04-350249

Published: 2011

Includes: Supplemental data

Journal Articles

Determinants of Platelet Counts in Patients with Chronic Graft Versus Host Disease.

Drazen Pulanic, MD, PhD, David Liewehr, MS, Seth Steinberg, PhD, Sandra A. Mitchell, CRNP, PhD, Kristin Baird, MD, Edward W. Cowen, MD, Galen Joe, MD, Kirsten M. Williams, MD, Daniele Avila, NP, Rachel B. Salit, MD, Niveen Atlam, Ashley Carpenter, RN, Fran Hakim, PhD, Michael Bishop, MD, Ronald E. Gress, MD, Steven Z. Pavletic, MD

Blood (2009) 114 (22): 2243.

https://doi.org/10.1182/blood.V114.22.2243.2243

Published: 2009

NARROW

A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease

Clinical Characterization and Cytokine Profile of Fatigue in Patients with Chronic Gvhd

A Large Cohort Comparison of 2005 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria to 2014 National Institutes of Health Chronic Graft-Versus-Host Disease Staging Criteria

Final Results of a Randomized Phase 2 Trial Evaluating Lower-Dose Versus Higher-Dose Pomalidomide as Therapy for Corticosteroid-Refractory Chronic Gvhd

Clinical and Immunologic Characteristics of Patients with Chronic Graft-Versus-Host Disease Persisting Seven or More Years after Diagnosis

Comorbidity Significantly Impairs Quality Of Life In Patients After Allogeneic Hematopoietic Stem Cell Transplantation – Results From The Prospective German Multicenter Validation Trial

Development and Preliminary Testing Of The Post-Transplant Multimorbidity Index (PTMI)

Chronic Graft-Versus-Host Disease (cGVHD) Patients with Bronchiolitis Obliterans Syndrome (BOS) Have Worse Clinical Manifestations and Severity of cGVHD with More Impairment in Self-Assessed Physical and Mental Health than cGVHD Patients without BOS

Assessing the Validity of the NIH Response Criteria for Chronic Graft-Versus-Host Disease (cGVHD): Consensus Measures Correlate with Clinical Outcomes,

Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease

Determinants of Platelet Counts in Patients with Chronic Graft Versus Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only